Borderline definitions: EU industry needs guidance on medicinal products elements
This article was originally published in Clinica
Executive Summary
The medical devices industry needs guidance to better understand the borderline between pharma and medical device regulations and on the relative roles of the pharma authorities and medical device notified bodies in the consultation on the medicinal element of the combination product.